Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anakinra prevents high glucose-mediated potentiation of IL-1β-induced NLRP3 inflammasome activation, small extracellular vesicle release and vascular inflammation.

Biochemical pharmacology·2026
Same author

Compressive Coronary Hematoma Treated With Stenting: From Early Malapposition to 9-Year Recovery in Systemic Disease.

JACC. Case reports·2026
Same author

Primary cilia disruption reprograms extracellular vesicle signaling in endothelial dysfunction and cardiovascular disease.

Life sciences·2026
Same author

Simtuzumab Attenuates Loxl2-Mediated Extracellular Matrix Remodeling and Preserves Cardiac Function in <i>LMNA</i> Mutation-Induced Dilated Cardiomyopathy.

Circulation. Heart failure·2026
Same author

Missed Opportunity for Fibrinolysis in ST-Segment-Elevation Myocardial Infarction: The Nationwide France-PCI Registry.

European heart journal. Quality of care & clinical outcomes·2026
Same author

Management and outcomes of patients with ST-segment elevation myocardial infarction and large infarct-related arteries.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026

Related Experiment Video

Updated: May 19, 2026

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

Microparticle release in remote ischemic conditioning mechanism.

Julien Jeanneteau1, Pierre Hibert, Maria Carmen Martinez

  • 1Université d'Angers, laboratoire Cardioprotection, Remodelage et Thrombose, Angers, France.

American Journal of Physiology. Heart and Circulatory Physiology
|August 14, 2012
PubMed
Summary
This summary is machine-generated.

Remote ischemic conditioning (RCond) protects the heart during myocardial infarction. However, this study found that microparticles (MPs) released during RCond did not mediate this cardioprotective effect in rats.

More Related Videos

Remotely Triggered LAD Occlusion Using a Balloon Catheter in Spontaneously Breathing Mice
07:17

Remotely Triggered LAD Occlusion Using a Balloon Catheter in Spontaneously Breathing Mice

Published on: March 22, 2024

Dynamic Assessments of Coronary Flow Reserve after Myocardial Ischemia Reperfusion in Mice
05:07

Dynamic Assessments of Coronary Flow Reserve after Myocardial Ischemia Reperfusion in Mice

Published on: August 25, 2023

Related Experiment Videos

Last Updated: May 19, 2026

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

Remotely Triggered LAD Occlusion Using a Balloon Catheter in Spontaneously Breathing Mice
07:17

Remotely Triggered LAD Occlusion Using a Balloon Catheter in Spontaneously Breathing Mice

Published on: March 22, 2024

Dynamic Assessments of Coronary Flow Reserve after Myocardial Ischemia Reperfusion in Mice
05:07

Dynamic Assessments of Coronary Flow Reserve after Myocardial Ischemia Reperfusion in Mice

Published on: August 25, 2023

Area of Science:

  • Cardiovascular Science
  • Regenerative Medicine
  • Cell Biology

Background:

  • Remote ischemic conditioning (RCond) is a promising cardioprotective strategy for acute myocardial infarction.
  • The underlying mechanism of RCond remains largely unknown, with a suspected humoral factor involved.
  • Circulating microparticles (MPs) were investigated as a potential mediator of RCond's effects.

Purpose of the Study:

  • To investigate the role of circulating microparticles (MPs) in mediating the cardioprotective effects of remote ischemic conditioning (RCond).
  • To characterize MPs released from remote tissues during RCond in both rats and humans.
  • To determine if RCond-derived MPs can replicate the infarct-limiting effects of RCond.

Main Methods:

  • RCond was induced in rats via limb ischemia and in humans using a blood pressure cuff.
  • MPs from RCond-treated rats and humans were characterized for endothelial and procoagulant markers.
  • Rats with myocardial infarction were treated with RCond or RCond-derived MPs, and infarct size was measured.

Main Results:

  • RCond significantly reduced infarct size in rats compared to the myocardial infarction-only group (24.4% vs. 54.6%).
  • RCond led to a marked increase in endothelial and procoagulant MPs in both rats and humans.
  • Administration of RCond-derived MPs did not reduce infarct size compared to controls.

Conclusions:

  • RCond effectively reduces infarct size in a rat model of myocardial infarction.
  • While RCond increases circulating MPs, these MPs do not appear to be the primary mediators of RCond's cardioprotective effects.
  • Further research is needed to elucidate the exact humoral factors responsible for RCond-induced cardioprotection.